Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved]
Background: Several smoke-free tobacco and/or nicotine-containing products (TNP) have emerged in recent years to support tobacco harm reduction strategies and reduce individual health risks and population harm relative to continued cigarette smoking. This paper describes the nationwide prevalence an...
Gespeichert in:
Veröffentlicht in: | F1000 research 2022, Vol.10, p.504 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 504 |
container_title | F1000 research |
container_volume | 10 |
creator | Afolalu, Esther F Langer, Peter Fischer, Karina Roulet, Steve Magnani, Pierpaolo |
description | Background: Several smoke-free tobacco and/or nicotine-containing products (TNP) have emerged in recent years to support tobacco harm reduction strategies and reduce individual health risks and population harm relative to continued cigarette smoking. This paper describes the nationwide prevalence and patterns of TNP use in Japan following the commercialization of one such smoke-free TNP, the heated tobacco product
IQOS® (Philip Morris International).
Methods: We analyzed the first annual data (2016-2017) of two repeated cross-sectional surveys conducted in a representative sample of the Japanese general adult (≥20 years of age) population (N = 4,878) and a sample of adult
IQOS users (N = 2,000). We assessed the prevalence of current TNP use according to type of product (cigarettes,
IQOS, e-cigarettes, and other TNPs) in the general population and patterns of TNP use in the
IQOS user sample.
Results: The prevalence of current use across all TNP in the sampled general population was 18.5% (95% confidence interval 17.2-19.5%), with 17.5% (16.4-18.6%) for cigarette smoking and 1.8% (1.4-2.2%) for
IQOS use. Regarding the distribution of patterns of use in the
IQOS user survey, the majority (63.4% [61.2-65.6%]) were exclusive users of
IQOS, followed by 20.6% (18.7-22.5%) of individuals who reported dual use of
IQOS and cigarettes.
Conclusions: In Japan, cigarette smoking remains the most prevalent way of consuming TNP; however,
IQOS is being adopted by a growing number of adult Japanese smokers. These findings serve as baseline data for monitoring trends over time in the use and adoption of potential smoke-free TNP in Japan. |
doi_str_mv | 10.12688/f1000research.52407.2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9069173</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2671930722</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3852-d8fbeaa059283f659d39a2cedef81d0aa758adc6e6483049484425814a30e95e3</originalsourceid><addsrcrecordid>eNqFkt1qFDEUxwdRbKl9BQl4s73Ybb5mJllBkOJHpVBFvRIJZ5Mz7pTZZJpkVvalfAjxwZzdrYv1xquEc37_H4fDKYqnjM4Yr5Q6bxilNGJCiHY5K7mk9Yw_KI45ldWUScof_vU_Kk5TuhkDVGtR8fpxcSTKkitd8uPi1_uIa-jQWyTgHekhZ4w-kdCQHBZgbdjWz0MkvrUhtx5JH4MbbCZDQtJ68g568GTCKavPCDRjnOQlkg4Gb5dbD5AlQkZ3EP4RTMjlh-uP5OePs_kI2RhSmia0uQ0eOpLy4DbkyxpjGguEPyc9ju5x3ha_zwkn0I-iNbqvT4pHDXQJT-_ek-Lz61efLt5Or67fXF68vJpaoUo-dapZIAAtNVeiqUrthAZu0WGjmKMAdanA2QorqQSVWiopeamYBEFRlyhOihd7bz8sVugs-hyhM31sVxA3JkBr7nd8uzTfwtpoWmlWi1EwuRPEcDtgymbVJotdBx7DkIxgQtJKSrpFn_2D3oQhjntJhlc104LWnI9Utad2y4vYHIZh1Oxuxdy7FbO7FbMNzvfBBuzQ5c0WMgfqP-Hfhy_HLg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2671930722</pqid></control><display><type>article</type><title>Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved]</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Afolalu, Esther F ; Langer, Peter ; Fischer, Karina ; Roulet, Steve ; Magnani, Pierpaolo</creator><creatorcontrib>Afolalu, Esther F ; Langer, Peter ; Fischer, Karina ; Roulet, Steve ; Magnani, Pierpaolo</creatorcontrib><description>Background: Several smoke-free tobacco and/or nicotine-containing products (TNP) have emerged in recent years to support tobacco harm reduction strategies and reduce individual health risks and population harm relative to continued cigarette smoking. This paper describes the nationwide prevalence and patterns of TNP use in Japan following the commercialization of one such smoke-free TNP, the heated tobacco product
IQOS® (Philip Morris International).
Methods: We analyzed the first annual data (2016-2017) of two repeated cross-sectional surveys conducted in a representative sample of the Japanese general adult (≥20 years of age) population (N = 4,878) and a sample of adult
IQOS users (N = 2,000). We assessed the prevalence of current TNP use according to type of product (cigarettes,
IQOS, e-cigarettes, and other TNPs) in the general population and patterns of TNP use in the
IQOS user sample.
Results: The prevalence of current use across all TNP in the sampled general population was 18.5% (95% confidence interval 17.2-19.5%), with 17.5% (16.4-18.6%) for cigarette smoking and 1.8% (1.4-2.2%) for
IQOS use. Regarding the distribution of patterns of use in the
IQOS user survey, the majority (63.4% [61.2-65.6%]) were exclusive users of
IQOS, followed by 20.6% (18.7-22.5%) of individuals who reported dual use of
IQOS and cigarettes.
Conclusions: In Japan, cigarette smoking remains the most prevalent way of consuming TNP; however,
IQOS is being adopted by a growing number of adult Japanese smokers. These findings serve as baseline data for monitoring trends over time in the use and adoption of potential smoke-free TNP in Japan.</description><identifier>ISSN: 2046-1402</identifier><identifier>EISSN: 2046-1402</identifier><identifier>DOI: 10.12688/f1000research.52407.2</identifier><identifier>PMID: 35528952</identifier><language>eng</language><publisher>London: Faculty of 1000 Ltd</publisher><subject>Aerosols ; Age ; Cigarette smoking ; Cigarettes ; Consumers ; Cross-sectional studies ; Field study ; Harm reduction ; Households ; Nicotine ; Polls & surveys ; Population ; Questionnaires ; Risk assessment ; Sample size ; Tobacco</subject><ispartof>F1000 research, 2022, Vol.10, p.504</ispartof><rights>Copyright: © 2022 Afolalu EF et al.</rights><rights>Copyright: © 2022 Afolalu EF et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © 2022 Afolalu EF et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3852-d8fbeaa059283f659d39a2cedef81d0aa758adc6e6483049484425814a30e95e3</citedby><cites>FETCH-LOGICAL-c3852-d8fbeaa059283f659d39a2cedef81d0aa758adc6e6483049484425814a30e95e3</cites><orcidid>0000-0001-8866-4765 ; 0000-0002-2596-8582</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069173/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069173/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,4024,27923,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Afolalu, Esther F</creatorcontrib><creatorcontrib>Langer, Peter</creatorcontrib><creatorcontrib>Fischer, Karina</creatorcontrib><creatorcontrib>Roulet, Steve</creatorcontrib><creatorcontrib>Magnani, Pierpaolo</creatorcontrib><title>Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved]</title><title>F1000 research</title><description>Background: Several smoke-free tobacco and/or nicotine-containing products (TNP) have emerged in recent years to support tobacco harm reduction strategies and reduce individual health risks and population harm relative to continued cigarette smoking. This paper describes the nationwide prevalence and patterns of TNP use in Japan following the commercialization of one such smoke-free TNP, the heated tobacco product
IQOS® (Philip Morris International).
Methods: We analyzed the first annual data (2016-2017) of two repeated cross-sectional surveys conducted in a representative sample of the Japanese general adult (≥20 years of age) population (N = 4,878) and a sample of adult
IQOS users (N = 2,000). We assessed the prevalence of current TNP use according to type of product (cigarettes,
IQOS, e-cigarettes, and other TNPs) in the general population and patterns of TNP use in the
IQOS user sample.
Results: The prevalence of current use across all TNP in the sampled general population was 18.5% (95% confidence interval 17.2-19.5%), with 17.5% (16.4-18.6%) for cigarette smoking and 1.8% (1.4-2.2%) for
IQOS use. Regarding the distribution of patterns of use in the
IQOS user survey, the majority (63.4% [61.2-65.6%]) were exclusive users of
IQOS, followed by 20.6% (18.7-22.5%) of individuals who reported dual use of
IQOS and cigarettes.
Conclusions: In Japan, cigarette smoking remains the most prevalent way of consuming TNP; however,
IQOS is being adopted by a growing number of adult Japanese smokers. These findings serve as baseline data for monitoring trends over time in the use and adoption of potential smoke-free TNP in Japan.</description><subject>Aerosols</subject><subject>Age</subject><subject>Cigarette smoking</subject><subject>Cigarettes</subject><subject>Consumers</subject><subject>Cross-sectional studies</subject><subject>Field study</subject><subject>Harm reduction</subject><subject>Households</subject><subject>Nicotine</subject><subject>Polls & surveys</subject><subject>Population</subject><subject>Questionnaires</subject><subject>Risk assessment</subject><subject>Sample size</subject><subject>Tobacco</subject><issn>2046-1402</issn><issn>2046-1402</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkt1qFDEUxwdRbKl9BQl4s73Ybb5mJllBkOJHpVBFvRIJZ5Mz7pTZZJpkVvalfAjxwZzdrYv1xquEc37_H4fDKYqnjM4Yr5Q6bxilNGJCiHY5K7mk9Yw_KI45ldWUScof_vU_Kk5TuhkDVGtR8fpxcSTKkitd8uPi1_uIa-jQWyTgHekhZ4w-kdCQHBZgbdjWz0MkvrUhtx5JH4MbbCZDQtJ68g568GTCKavPCDRjnOQlkg4Gb5dbD5AlQkZ3EP4RTMjlh-uP5OePs_kI2RhSmia0uQ0eOpLy4DbkyxpjGguEPyc9ju5x3ha_zwkn0I-iNbqvT4pHDXQJT-_ek-Lz61efLt5Or67fXF68vJpaoUo-dapZIAAtNVeiqUrthAZu0WGjmKMAdanA2QorqQSVWiopeamYBEFRlyhOihd7bz8sVugs-hyhM31sVxA3JkBr7nd8uzTfwtpoWmlWi1EwuRPEcDtgymbVJotdBx7DkIxgQtJKSrpFn_2D3oQhjntJhlc104LWnI9Utad2y4vYHIZh1Oxuxdy7FbO7FbMNzvfBBuzQ5c0WMgfqP-Hfhy_HLg</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Afolalu, Esther F</creator><creator>Langer, Peter</creator><creator>Fischer, Karina</creator><creator>Roulet, Steve</creator><creator>Magnani, Pierpaolo</creator><general>Faculty of 1000 Ltd</general><general>F1000 Research Limited</general><scope>C-E</scope><scope>CH4</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8866-4765</orcidid><orcidid>https://orcid.org/0000-0002-2596-8582</orcidid></search><sort><creationdate>2022</creationdate><title>Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved]</title><author>Afolalu, Esther F ; Langer, Peter ; Fischer, Karina ; Roulet, Steve ; Magnani, Pierpaolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3852-d8fbeaa059283f659d39a2cedef81d0aa758adc6e6483049484425814a30e95e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aerosols</topic><topic>Age</topic><topic>Cigarette smoking</topic><topic>Cigarettes</topic><topic>Consumers</topic><topic>Cross-sectional studies</topic><topic>Field study</topic><topic>Harm reduction</topic><topic>Households</topic><topic>Nicotine</topic><topic>Polls & surveys</topic><topic>Population</topic><topic>Questionnaires</topic><topic>Risk assessment</topic><topic>Sample size</topic><topic>Tobacco</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Afolalu, Esther F</creatorcontrib><creatorcontrib>Langer, Peter</creatorcontrib><creatorcontrib>Fischer, Karina</creatorcontrib><creatorcontrib>Roulet, Steve</creatorcontrib><creatorcontrib>Magnani, Pierpaolo</creatorcontrib><collection>F1000Research</collection><collection>Faculty of 1000</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>F1000 research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Afolalu, Esther F</au><au>Langer, Peter</au><au>Fischer, Karina</au><au>Roulet, Steve</au><au>Magnani, Pierpaolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved]</atitle><jtitle>F1000 research</jtitle><date>2022</date><risdate>2022</risdate><volume>10</volume><spage>504</spage><pages>504-</pages><issn>2046-1402</issn><eissn>2046-1402</eissn><abstract>Background: Several smoke-free tobacco and/or nicotine-containing products (TNP) have emerged in recent years to support tobacco harm reduction strategies and reduce individual health risks and population harm relative to continued cigarette smoking. This paper describes the nationwide prevalence and patterns of TNP use in Japan following the commercialization of one such smoke-free TNP, the heated tobacco product
IQOS® (Philip Morris International).
Methods: We analyzed the first annual data (2016-2017) of two repeated cross-sectional surveys conducted in a representative sample of the Japanese general adult (≥20 years of age) population (N = 4,878) and a sample of adult
IQOS users (N = 2,000). We assessed the prevalence of current TNP use according to type of product (cigarettes,
IQOS, e-cigarettes, and other TNPs) in the general population and patterns of TNP use in the
IQOS user sample.
Results: The prevalence of current use across all TNP in the sampled general population was 18.5% (95% confidence interval 17.2-19.5%), with 17.5% (16.4-18.6%) for cigarette smoking and 1.8% (1.4-2.2%) for
IQOS use. Regarding the distribution of patterns of use in the
IQOS user survey, the majority (63.4% [61.2-65.6%]) were exclusive users of
IQOS, followed by 20.6% (18.7-22.5%) of individuals who reported dual use of
IQOS and cigarettes.
Conclusions: In Japan, cigarette smoking remains the most prevalent way of consuming TNP; however,
IQOS is being adopted by a growing number of adult Japanese smokers. These findings serve as baseline data for monitoring trends over time in the use and adoption of potential smoke-free TNP in Japan.</abstract><cop>London</cop><pub>Faculty of 1000 Ltd</pub><pmid>35528952</pmid><doi>10.12688/f1000research.52407.2</doi><orcidid>https://orcid.org/0000-0001-8866-4765</orcidid><orcidid>https://orcid.org/0000-0002-2596-8582</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2046-1402 |
ispartof | F1000 research, 2022, Vol.10, p.504 |
issn | 2046-1402 2046-1402 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9069173 |
source | DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Aerosols Age Cigarette smoking Cigarettes Consumers Cross-sectional studies Field study Harm reduction Households Nicotine Polls & surveys Population Questionnaires Risk assessment Sample size Tobacco |
title | Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved] |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T01%3A05%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20patterns%20of%20tobacco%20and/or%20nicotine%20product%20use%20in%20Japan%20(2017)%20after%20the%20launch%20of%20a%20heated%20tobacco%20product%20(%20IQOS%20%C2%AE):%20a%20cross-sectional%20study%20%5Bversion%202;%20peer%20review:%202%20approved%5D&rft.jtitle=F1000%20research&rft.au=Afolalu,%20Esther%20F&rft.date=2022&rft.volume=10&rft.spage=504&rft.pages=504-&rft.issn=2046-1402&rft.eissn=2046-1402&rft_id=info:doi/10.12688/f1000research.52407.2&rft_dat=%3Cproquest_pubme%3E2671930722%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2671930722&rft_id=info:pmid/35528952&rfr_iscdi=true |